Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2023-08-07 Director's Dealing
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
112年07月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings and pledged shares by company insiders, including directors and senior management. It lists current holdings, pledged shares, and related percentages. The content focuses on insider share transactions and holdings rather than financial results, governance policies, or meeting materials. There is no indication of a report publication or announcement, nor is there financial data or management discussion. The document fits the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives (insider trades). The document length is short (2424 characters), but it contains substantive data on insider holdings, not just an announcement or certification. Therefore, the appropriate classification is Director's Dealing (DIRS).
2023-08-07 Chinese
112年年報及股東會資料 — 2023_1786_20230628F05.pdf
Annual Report Classification · 95% confidence The document contains detailed content from a shareholders' meeting including approval of the annual business report and financial statements for the fiscal year 111 (which corresponds to 2022 in the Gregorian calendar), election of directors, dividend distribution proposals, amendments to the board meeting rules and company articles, and voting results. It also includes the auditor's report from Ernst & Young with an unqualified opinion on the financial statements. The document is lengthy (15,000 characters) and contains substantive financial data, business performance analysis, and governance matters. This matches the characteristics of an Annual Report (10-K) rather than just an announcement or proxy materials. The presence of audited financial statements and detailed management discussion confirms this classification. Therefore, the filing type is Annual Report (10-K). FY 2022
2023-07-11 Chinese
112年年報及股東會資料 — 2022_1786_20230628F04.pdf
Annual Report Classification · 100% confidence The document is titled as an "年報" which translates to "Annual Report" for the fiscal year 111 (2022). It contains detailed sections typical of an annual report, including a letter to shareholders, company overview, corporate governance report, financial overview, and audited financial statements. The presence of auditor names and audit firm (Ernst & Young) further supports this. The document length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or summary. Therefore, this document is classified as an Annual Report (10-K). FY 2022
2023-07-11 Chinese
112年年報及股東會資料 — 2022_1786_20230628FE4.pdf
Annual Report Classification · 100% confidence The document is titled 'Annual Report' for the year 2022 of Scivision Biotech Inc. It contains detailed sections typical of an annual report, including a report to shareholders, company profile, corporate governance report, fundraising, business overview, financial overview, financial statements audited by CPAs, and management discussion and analysis. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of audited financial statements and comprehensive financial data confirms it is the official yearly report covering company activity and full financial performance. Therefore, the document fits the definition of an Annual Report (10-K). FY 2022
2023-07-11 Chinese
112年年報及股東會資料 — 2023_1786_20230628F17.pdf
Major Shareholding Notification Classification · 100% confidence The document contains detailed information about the top ten shareholders, their shareholdings, and their relationships as defined by accounting standards. It is a disclosure of major shareholding details, including familial and related party relationships among shareholders. There is no indication of financial statements, management discussion, or other report types. The content fits the definition of a Major Shareholding Notification, which reports changes or details in significant share ownership levels.
2023-07-11 Chinese
112年年報及股東會資料 — 2023_1786_20230628F02.pdf
Annual Report Classification · 100% confidence The document is a detailed agenda and handbook for the 112th Annual General Meeting (AGM) of Scivision Biotech Inc., including meeting procedures, agenda items such as reports, approvals, elections, discussions, and attachments. The attachments include the 111th fiscal year business report, audit committee reports, financial statements with auditor opinions, and other governance documents. The presence of the full business report, audited financial statements, auditor's report, and detailed financial data indicates this is the full Annual Report document rather than just an announcement or a summary. The document length is substantial (15,000 characters), and it contains comprehensive financial and operational information for the fiscal year, consistent with an Annual Report (10-K) filing. Therefore, the correct classification is Annual Report (10-K). FY 2022
2023-07-11 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.